Okayama, Taro
Naito, Tateaki http://orcid.org/0000-0003-4047-2929
Yonenaga, Yusuke
Ohashi, Takuya
Kitagawa, Midori
Mitsuhashi, Noriko
Ishi, Takeshi
Fuseya, Hiroshi
Aoyama, Takashi
Notsu, Akifumi
Mori, Keita
Mamesaya, Nobuaki
Kawamura, Takahisa
Kobayashi, Haruki
Omori, Shota
Wakuda, Kazushige
Ono, Akira
Kenmotsu, Hirotsugu
Murakami, Haruyasu
Tanuma, Akira
Takahashi, Toshiaki
Article History
Received: 14 July 2020
Accepted: 15 December 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: Mr. Okayama, Mr. Yonenaga, Mr. Ohashi, Ms. Kitagawa, Ms. Mitsuhashi, Mr. Ishi, Dr. Fuseya, Mr. Aoyama, Mr. Notsu, Mr. Mori, Dr. Mamesaya, Dr. Kawamura, Dr. Kobayashi, and Dr. Tanuma have nothing to disclose. Dr. Naito reports personal fees from Ono Pharmaceutical Co., Ltd., Pfizer Japan Inc., and Mochida Pharmaceutical Co., Ltd., which are unrelated to the submitted work. Dr. Omori reports personal fees from Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., and MSD K.K. Dr. Wakuda reports personal fees from Ono Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Boehringer Ingelheim Company., Eli Lilly K.K., and grants and personal fees from AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Novartis Pharma K.K., and grants from AbbVie Company. Dr. Ono reports personal fees from Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., AstraZeneca K.K., Eli Lilly K.K., MSD K.K., and Novartis Pharma K.K. Dr. Kenmotsu reports personal fees from Ono Pharmaceutical Co., Ltd., Eli Lilly K.K., Kyowa Hakko Kirin Co., Ltd., Bristol-Myers Squibb Company, MSD K.K., Novartis Pharma K.K., and grants from Daiichi-Sankyo Co., Ltd., and grants and personal fees from Chugai Pharmaceutical Co., Ltd., Boehringer Ingelheim Company, and AstraZeneca K.K., which are unrelated to the submitted work. Dr. Murakami reports personal fees from Bristol-Myers Squibb Company, Ono Pharmaceutical Co., Ltd., MSD K.K., and grants from AbbVie Company, Daiichi-Sankyo Co., Ltd., IQvia Company, and grants and personal fees from AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Eli Lilly K.K., Taiho Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd., which are unrelated to the submitted work. Dr. Takahashi reports grants from Japan Agency for Medical Research and Development during the conduct of the study, and personal fees from Boehringer Ingelheim Company, Roche Diagnostics K.K., and grants and personal fees from AstraZeneca K.K., Chugai Pharmaceutical Co., LTD., Eli Lilly K.K., Ono Pharmaceutical Co., Ltd., MSD K.K., and Pfizer Japan Inc., which are unrelated to the submitted work.
: Informed consent was obtained from all participants included in the study.
: Informed consent was obtained for the data analysis and publication from all individual participants.
: Not applicable.